Treatment of the studied melanoma cell lines with protein kinases inhibitors, regarding the inhibition of cell invasiveness in vitro as well as the activity of metalloproteinases 2 and 9 gave the best results in the case of the use of B-RAF kinase inhibitor—PLX-4032. Here, WEE1 is linked to melanoma.